Status:
COMPLETED
Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo School of Pharmacy
Conditions:
Muscular Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary objective of the study is to investigate whether differences in atorvastatin metabolite ratios might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicity...
Detailed Description
The primary objective of the study is to investigate whether differences in atorvastatin metabolites ratios might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicit...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Suspected atorvastatin induced muscle adverse events
- Signed informed consent
- 18 years of age or older
- Able to donate blood samples
- Ongoing treatment with atorvastatin (not necessary if patients only donate a muscle biopsy)
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00199745
Start Date
October 1 2005
End Date
December 1 2008
Last Update
May 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lipidklinikken, Rikshospitalet-Radiumhospitalet HF
Oslo, Oslo County, Norway, 0027